Your Messages Inbox
Your Article Summary
See Latest ArticlesLong-Term Medtronic Device Registry First to Show How Implantable Heart Devices Work in Real-World Clinical Practice
Medtronic, 05/15/09
The first results from the Medtronic Inc., OMNI Study were released today at Heart Rhythm 2009, the annual congress of the Heart Rhythm Society, revealing that one out of six patients with implantable cardioverter-defibrillator or cardiac resynchronization therapy-defibrillators to prevent sudden cardiac arrest, received potentially life-saving medical therapy – either in the form of anti-tachycardia pacing or a shock for dangerously fast heart rhythms – within a period of two years following their implant. Further, the study showed that patients received therapy at similar rates, regardless of whether they meet current medical society guidelines.
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
Amgen, 12/04/09
Genzyme Begins Shipping Newly Produced Cerezyme from Allston Plant
Genzyme, 12/02/09
Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09
Article Search
Sponsor